Drooid Logo
Back to today’s briefing

Story perspectives

New Tariffs on Medicines Could Spike Patient Costs

8/26/2025

39 4 Full Breakdown

1 of 3

Trump's Tariff Threat
  • A new 15% tariff on European-branded medicines may raise costs for patients using GLP-1 drugs like Ozempic.
  • The US-EU trade agreement, finalized on August 21, 2025, aims to strengthen supply chains and economic security.
  • President Trump threatened additional tariffs on countries with perceived discriminatory digital regulations, risking US-EU relations.
  • EU Commission President Ursula von der Leyen highlighted the deal's significance in preventing a trade war.
1 / 3